San Antonio Business Journal (March 19, 2021) Several major national medical groups are calling on the Centers for Medicare & Medicaid Services to update lung cancer screening coverage to significantly expanding access to such tests.
read moreMarch 3, 2021 (San Antonio, TX) bioAffinity Technologies, a privately held company focused on early diagnostics and cancer therapeutics, announced that a scientific paper that explains how porphyrins are selectively incorporated into cancer cells has been published in the Journal of the Federation of Societies for the Study of Experimental Biology (FASEB Journal).
read moreSan Antonio Business Journal (February 8, 2021) “China represents a $5 billion market for CyPath© Lung. An estimated 780,000 people will be diagnosed annually in China with lung cancer, most often at late stage,” bioAffinity President and CEO Maria Zannes said. "Fosun Long March is a driving force in health care, bringing medical breakthroughs to China and the world that improve the health and clinical outcomes of patients.”
read moreFebruary 4, 2021 (San Antonio, TX) China’s leading healthcare company to evaluate bioAffinity’s non-invasive, highly accurate test for early-stage lung cancer with aim to commercialize in world’s largest market
read moreDiagnostics World News (January 19, 2021) A validation trial of a test looking at lung cancer’s micro-environment offers promising results. Using flow cytometry, an instrument that interrogates individual cells in a fraction of seconds, the early lung cancer diagnostic used AI-generated automated analysis of sputum to identify, among others, defining factors in the micro-environment of the lung that characterize cancer in people at high risk for the disease.
read more
bioAffinity Technologies was selected as one of San Antonio’s Top 2020 Innovators. In this video, you will see Maria Zannes, President and Chief Executive Officer, speak about what drives motivation, innovation and success and kick off San Antonio’s premier annual event celebrating the City’s healthcare and bioscience industry.